KIR and HLA in cis and trans cooperatively shape human NK education
顺式和反式的 KIR 和 HLA 合作塑造人类 NK 教育
基本信息
- 批准号:9310137
- 负责人:
- 金额:$ 42.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-03 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acute leukemiaAffinityAllogenicAllograftingBindingBone MarrowCD34 geneCell TherapyCell TransplantsCell surfaceCellsChimera organismDevelopmentDiseaseDonor SelectionEducationEnergy TransferEngraftmentEnvironmentEvaluationExhibitsExposure toFailureGene FamilyGeneticGoalsHLA AntigensHematologic NeoplasmsHematopoieticHematopoietic Stem Cell TransplantationHistocompatibility Antigens Class IHumanImmuneImmune systemImmunityImmunogeneticsImmunologyIn VitroInflammatoryInnate Immune SystemInterruptionInvestigationKnowledgeLicensingLigandsLigationLymphocyteMediatingMembraneMissionMolecularMonoclonal AntibodiesMouse StrainsMusNatural Killer CellsPatientsPlayPopulationProteinsPublic HealthRNA InterferenceRelapseResearchRoleSamplingShapesSolidStem cellsStudy SubjectSystemTechnologyTestingTransgenic MiceTransgenic OrganismsTransplant RecipientsTransplantationUmbilical Cord BloodUnited States National Institutes of HealthVirusVirus Diseasescancer cellcancer therapyclinically relevantcytotoxicityhematopoietic cell transplantationhumanized mousein vivoin vivo Modelkillingsleukemiamouse modelnon-Nativenovelreceptorrelapse riskresponsetherapy designtumor
项目摘要
PROJECT SUMMARY
Natural Killer (NK) cells are highly relevant in the setting of hematopoietic stem cell transplantation (HCT),
where their activity can drastically reduce the risk of relapse in leukemia patients. Despite advances in donor
selection to minimize transplant complications, leukemia relapse remains one of the most devastating causes
of transplant failure. There is a general lack of knowledge of how NK cell populations are educated for effector
function, leukemia recognition and clearance. While it is known that interaction between HLA class I molecules
and the inhibitory killer Ig-like receptors (KIR) are important for NK education or “licensing” for effector function,
the orientation of their interaction, the factors that contribute to the strength of their interaction, and the relative
contributions of donor and recipient HLA are not known.
A major impediment to fundamental human NK studies has been the lack of in vivo models that
faithfully recapitulate NK education. A humanized NOD-RAG2IL2Rγc-/- mouse strain that exhibits HLA-B*27:05
successfully permits engraftment of mature NK cells and development of functional human NK cells from
CD34+ stem cells. Preliminary investigations reveal that in vivo environments expressing cognate HLA educate
developing and transferred KIR-expressing NK cells and enhance their long-term survival. In parallel, FRET
and RNAi technology reveals that cis-interaction between HLA and KIR intrinsic to the cell also facilitates NK
education. Evidence that HLA molecules can be transferred onto NK cells from adjacent cells provokes
investigation of trogocytosis as a mechanism by which trans HLA may permit education via cis ligation of KIR.
Restriction of HLA expression to the hematopoietic or stromal compartments in bone marrow chimeras
will help define the relative contributions of donor and recipient HLA to NK licensing and persistence. Receptor-
ligand pairs known to bind in trans also interact in cis, and further clarification is required to understand how
these interactions influence NK function. Competition between cis-trans binding will test the hypothesis that cis
interactions facilitate NK responsiveness by shielding KIR from ligation of trans HLA. NK cells with and without
non-native HLA expression will be functionally tested to better understand how trogocytosis contributes to NK
education after continuous or interrupted exposure to cognate HLA. Finally, experimental findings from the
humanized mouse model and in vitro studies will be verified in a fully human system using NK cells obtained
from patients who have received an HLA-mismatched umbilical cord blood transplant.
These goals will advance our understanding of fundamental molecular requirements for NK education
and acquisition of effector function. A deeper understanding of licensing by HLA provided in cis and trans will
inform donor selection in hematopoietic cell transplantation and adoptive NK cell therapies for the treatment of
cancer.
项目摘要
自然杀伤(NK)细胞在造血干细胞移植(HCT)的环境中高度相关,
它们的活性可以大大降低白血病患者复发的风险。尽管捐助方取得了进展,
选择,以尽量减少移植并发症,白血病复发仍然是最具破坏性的原因之一
移植失败。目前普遍缺乏关于NK细胞群体如何被训练用于效应细胞的知识。
功能,白血病识别和清除。虽然已知HLA I类分子之间的相互作用
并且抑制性杀伤Ig样受体(KIR)对于NK教育或效应器功能的"许可"是重要的,
它们相互作用的方向,有助于它们相互作用强度的因素,以及相对的
供体和受体HLA的贡献是未知的。
基础人类NK研究的主要障碍是缺乏体内模型,
忠实地概括NK教育。显示HLA-B * 27:05的人源化NOD-RAG2IL2R γ c-/-小鼠品系
成功地允许成熟NK细胞的植入和功能性人NK细胞的发育
CD34+干细胞。初步研究表明,在体内环境表达同源HLA教育,
开发和转移表达KIR的NK细胞,并提高其长期存活率。与此同时,FRET
RNAi技术揭示了细胞固有的HLA和KIR之间的顺式相互作用也促进了NK细胞的增殖。
教育HLA分子可以从邻近细胞转移到NK细胞上的证据引起了
作为一种机制,反式HLA可以通过KIR顺式连接进行教育的研究。
骨髓嵌合体中HLA表达对造血或基质区室的限制
将有助于确定供体和受体HLA对NK许可和持久性的相对贡献。受体-
已知反式结合的配体对也以顺式相互作用,需要进一步澄清以了解如何
这些相互作用影响NK功能。顺式-反式结合之间的竞争将检验顺式
相互作用通过保护KIR免受反式HLA的连接而促进NK反应性。NK细胞有和没有
将对非天然HLA表达进行功能性测试,以更好地了解棘红细胞增多症如何有助于NK细胞增殖。
在连续或中断暴露于同源HLA后进行教育。最后,实验结果从
人源化小鼠模型和体外研究将使用获得的NK细胞在全人系统中进行验证。
来自接受HLA不匹配的脐带血移植的患者。
这些目标将促进我们对NK教育的基本分子要求的理解
和获得效应器功能。更深入地了解HLA在顺式和反式中提供的许可,
在造血细胞移植和过继性NK细胞疗法中选择供者,
癌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHARINE C HSU其他文献
KATHARINE C HSU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHARINE C HSU', 18)}}的其他基金
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
HCMV 诱导的先天样 CD8 T 细胞和同种异体 HCT 结果
- 批准号:
10390447 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
机器学习与免疫遗传学预测造血细胞移植结果
- 批准号:
10322105 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
HCMV 诱导的先天样 CD8 T 细胞和同种异体 HCT 结果
- 批准号:
10590647 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
机器学习与免疫遗传学预测造血细胞移植结果
- 批准号:
10534187 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Natural killer cell and T-cell crosstalk in CMV infection
CMV 感染中的自然杀伤细胞和 T 细胞串扰
- 批准号:
9398188 - 财政年份:2017
- 资助金额:
$ 42.85万 - 项目类别:
KIR and HLA in cis and trans cooperatively shape human NK education
顺式和反式的 KIR 和 HLA 合作塑造人类 NK 教育
- 批准号:
9160652 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma
人源化 3F8 MoAb (IND 112594) 和 NK 细胞 (IND BB-13399) 治疗神经母细胞瘤的 I 期研究
- 批准号:
9488351 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
基于KIR和HLA基因型的同种异体造血细胞供体选择
- 批准号:
9271228 - 财政年份:2015
- 资助金额:
$ 42.85万 - 项目类别:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
基于KIR和HLA基因型的同种异体造血细胞供体选择
- 批准号:
8865414 - 财政年份:2015
- 资助金额:
$ 42.85万 - 项目类别:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
神经母细胞瘤的联合免疫治疗:先天肿瘤免疫模型
- 批准号:
8508896 - 财政年份:2012
- 资助金额:
$ 42.85万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Continuing Grant